Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Stéphanie Henry"'
Autor:
Benjamin Lardinois, Laurence Miller, Adrien Randazzo, Terry Laurent, Régis Debois, Stéphanie Henry
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1248-1253 (2021)
In the cerebrospinal fluid (CSF), the demonstration of malignant cells by cytological examination is currently the gold standard for the diagnosis of leptomeningeal carcinomatosis (LC). However, a positive cytology is observed in only 50–60% of pat
Externí odkaz:
https://doaj.org/article/54dd2b0d1c6645258753e87ddf69fea9
Autor:
Emmanuel Seront, Sandra Schmitz, Matthias Papier, Aline van Maanen, Stéphanie Henry, Christophe Lonchay, Sylvie Rottey, Gabrielle van Caloen, Jean-Pascal Machiels
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: The majority of human papillomavirus (HPV)-negative squamous cell carcinoma of the head and neck (SCCHN) present upregulation of the epidermal growth factor receptor (EGFR) and frequent alterations in the cyclin D1-cyclin dependent kinase
Externí odkaz:
https://doaj.org/article/e626e640653149deb474c4ae33543dd5
Autor:
Alix Devaux, Gabriela Beniuga, Claire Quaghebeur, Stéphanie Henry, Mieke Van Bockstal, Christine Galant, Paul Delrée, Jean-Luc Canon, Brigitte Honhon, Dominique Korman, Vincent Verschaeve, Christophe Lonchay, Sarah Lefevre, Lionel D’Hondt, Martine Berlière, Sophie Delmarcelle, Jean-Michel Mine, Timour Willems, Gebhard Müller, Nathalie Myant, Isabelle Bar, Sandy Haussy, Pierre G. Coulie, François P. Duhoux, Javier Carrasco
Publikováno v:
Cancer Research. 83:P4-07
Background: Neoadjuvant association of immune checkpoints inhibitors (ICI) and dose dense chemotherapy is promising for triple negative breast cancers (TNBC). However, response rates vary from one study to another. Timing, best chemotherapy partner a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b068f4919376854f308d00506f3390e5
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-16
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-16
Autor:
Emiel A. De Jaeghere, Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, Sandrine Aspeslagh, Alex De Caluwé, Eline Naert, Diether Lambrechts, An Hendrix, Olivier De Wever, Koen K. Van de Vijver, Frédéric Amant, Katrien Vandecasteele, Hannelore G. Denys
Publikováno v:
Cancer immunology and immunotherapy
CANCER IMMUNOLOGY IMMUNOTHERAPY
Cancer immunology, immunotherapy. Springer Science and Business Media Deutschland GmbH
CANCER IMMUNOLOGY IMMUNOTHERAPY
Cancer immunology, immunotherapy. Springer Science and Business Media Deutschland GmbH
A phase II study (PRIMMO) of patients with pretreated persistent/recurrent/metastatic cervical or endometrial cancer is presented. Patients received an immunomodulatory five-drug cocktail (IDC) consisting of low-dose cyclophosphamide, aspirin, lansop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b45ea94c03f75a8c1f21d6000fcad61
https://lirias.kuleuven.be/handle/20.500.12942/703074
https://lirias.kuleuven.be/handle/20.500.12942/703074
Autor:
Ignace Vergote, Stella Kim, Paul Ursell, Sandro Pignata, Antonio Gonzalez-Martin, Leslie Randall, Bohuslav Melichar, Kristine Madsen, Sven Mahner, Domenica Lorusso, Stéphanie Henry, Lydia Gaba, Theodora Salcedo, Haley Neff-Laford, Jeffrey Harris, Joy Jiang, Ibrahima Soumaoro, Shweta Jain, Bradley Monk, Robert L Coleman
Publikováno v:
E-Posters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e203d0914a05e695cd7b8fa5e2ec7ba4
https://doi.org/10.1136/ijgc-2022-igcs.155
https://doi.org/10.1136/ijgc-2022-igcs.155
Autor:
Emiel A De Jaeghere, Sandra Tuyaerts, An MT van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A van Dam, Sandrine Aspeslagh, Alex de Caluwé, Eline Naert, Diether Lambrechts, An Hendrix, Olivier de Wever, Koen K van de Vijver, Frédéric Amant, Katrien Vandecasteele, Hannelore G Denys
Publikováno v:
Miscellaneous.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb09e84bd04829deb43d0b565ee4d61c
https://doi.org/10.1136/ijgc-2022-esgo.401
https://doi.org/10.1136/ijgc-2022-esgo.401
Autor:
Florian Heitz, Christian Marth, Stéphanie Henry, Alexander Reuss, David Cibula, Lydia Gaba, Nicoletta Colombo, Sandra Polleis, Philipp Harter
Publikováno v:
Ovarian cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2971e8d037eaa2a2a23974197f55f44
https://doi.org/10.1136/ijgc-2022-esgo.590
https://doi.org/10.1136/ijgc-2022-esgo.590
Autor:
Liselore Loverix, Rawand Salihi, Anne-Sophie van Rompuy, Adriaan Vanderstichele, Els van Nieuwenhuysen, Thaïs Baert, Philip Debruyne, Nathalie Cornez, Stéphanie Henry, Patrick Neven, Sileny Han, Patrick Berteloot, Siel Olbrecht, Tina Laga, Pieter Busschaert, Toon van Gorp, Ignace Vergote
Publikováno v:
Cervical cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca567d00771696baf78f4640b997bea7
https://doi.org/10.1136/ijgc-2022-esgo.111
https://doi.org/10.1136/ijgc-2022-esgo.111
Autor:
Stéphanie Henry, Benjamin Lardinois, Terry Laurent, Régis Debois, Adrien Randazzo, Laurence Miller
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 2, Pp 1248-1253 (2021)
Case Reports in Oncology, Vol 14, Iss 2, Pp 1248-1253 (2021)
In the cerebrospinal fluid (CSF), the demonstration of malignant cells by cytological examination is currently the gold standard for the diagnosis of leptomeningeal carcinomatosis (LC). However, a positive cytology is observed in only 50–60% of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae4b18c0fa33e488871d5f6d9e8b4b3d
https://doi.org/10.1159/000518314
https://doi.org/10.1159/000518314
Autor:
Frederic Selle, Bernard Asselain, François Montestruc, Fernando Bazan, Beatriz Pardo, Vanda Salutari, Frederik Marmé, Anja Ør Knudsen, Alessandra Bologna, Radoslaw Madry, Rosalind Glasspool, Stéphanie Henry, Jacob Korach, Stephanie Lheureux, Bob Shaw, Ana Santaballa, Raffaella Cioffi, Ulrich Canzler, Alain Lortholary, Eric Pujade-Lauraine
Publikováno v:
Journal of Clinical Oncology. 40:5558-5558
5558 Background: In the Phase IIIb OReO/ENGOT Ov-38 trial (NCT03106987), maintenance olaparib (O) rechallenge significantly improved progression-free survival (PFS) vs placebo in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ffe7b3db3aec9fd316af811cbe84baa
https://doi.org/10.1200/jco.2022.40.16_suppl.5558
https://doi.org/10.1200/jco.2022.40.16_suppl.5558